ARID1A and TERT promoter mutations in dedifferentiated meningioma

While WHO grade I meningiomas are considered benign, patients with WHO grade III meningiomas have very high mortality. The principles underlying tumor progression in meningioma are largely unknown yet a detailed understanding of these mechanisms will be required for effective management of patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Genet
Päätekijät: Abedalthagafi, Malak S., Bi, Wenya Linda, Merrill, Parker H., Gibson, William J., Rose, Matthew F., Du, Ziming, Francis, Joshua M., Du, Rose, Dunn, Ian F., Ligon, Azra H., Beroukhim, Rameen, Santagata, Sandro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4882906/
https://ncbi.nlm.nih.gov/pubmed/25963524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cancergen.2015.03.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia